TGFB1 and autoimmune disease: These results have important implications in cancer immunotherapy and the treatment of autoimmune diseases, as TGFβ-insensitive cells would be ideal candidates for the adopted therapy of cancer and priority targets for the therapy of autoimmunity and graft immunity.